Results 151 to 160 of about 18,181 (226)

FDA's Approval Summary of the First Biosimilar to Natalizumab for the Treatment of Multiple Sclerosis and Crohn's Disease. [PDF]

open access: yesJ Clin Pharmacol
Delvadia PR   +17 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy